Further examination of this co-occurring mutation across all cancer studies on cBioPortal showed that this mutational relationship between DDR1 and either RUNX1 or CBFβ remained strongly significant, indicating that this axis is worth investigating outside of breast cancer. This evidence concerns the gene RUNX1 and breast cancer.